IPO Boutique

Atara Biotherapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Atara Biotherapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Atara Biotherapeutics, Inc.ATRA -
NASDAQ
$14.00-$16.00 $11.00 $9.895 million10/16/2014
Goldman Sachs & Co., Citigroup
Co-Manager(s):
Jefferies
Health Care
Filing(s):

Filed 2014-06-23
Terms Added 2014-07-10
Terms Added 2014-09-28



Atara Biotherapeutics, Inc. Quote & Chart - Click for current quote - ATRA

About Atara Biotherapeutics, Inc. (adapted from Atara Biotherapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology.

This description is adapted from Atara Biotherapeutics, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Atara Biotherapeutics, Inc. "ATRA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved